CAS Number 444088-20-4 Formula C10H17NO2 Molar mass 183.247 g/mol ChemSpider ID 19264101 | PubChem CID 10313401 3D model (Jmol) Interactive image Pubchem 10313401 | |
![]() | ||
PD-217,014 is a drug developed by Pfizer and related to gabapentin, which similarly binds to the α2δ calcium channels (1 and 2). It was developed as a potentially more potent successor to gabapentin and pregabalin, along with several other analogues such as atagabalin and 4-methylpregabalin, but while PD-217,014 produces visceral analgesic effects in animal studies with higher potency and efficacy than gabapentin, it was not developed further for clinical use because of its comparatively more complex synthesis, compared to other related analogues.
References
PD-217,014 Wikipedia(Text) CC BY-SA